Protalix BioTherapeutics (AMEX:PLX) reported its Q4 earnings results on Thursday, March 31, 2022 at 06:50 AM.
Here’s what investors need to know about the announcement.
Protalix BioTherapeutics missed estimated earnings by 27.27%, reporting an EPS of $-0.14 versus an estimate of $-0.11.
Revenue was down $10.95 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 4.35% drop in the share price the next day.
Here’s a look at Protalix BioTherapeutics’s past performance:
|Quarter||Q3 2021||Q2 2021||Q1 2021||Q4 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.